CNOT3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.991800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.794600E-01
Normal-vs-Stage2
7.913200E-01
Normal-vs-Stage3
4.152200E-01
Normal-vs-Stage4
4.494400E-01
Stage1-vs-Stage2
1.652800E-01
Stage1-vs-Stage3
2.313800E-01
Stage1-vs-Stage4
8.550000E-01
Stage2-vs-Stage3
2.004400E-01
Stage2-vs-Stage4
1.328640E-01
Stage3-vs-Stage4
1.330240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.164600E-01
Normal-vs-AfricanAmerican
9.613400E-01
Normal-vs-Asian
8.688800E-01
Caucasian-vs-AfricanAmerican
9.736600E-01
Caucasian-vs-Asian
8.817200E-01
AfricanAmerican-vs-Asian
9.202800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.558000E-01
Normal-vs-Female
8.394600E-01
Male-vs-Female
5.248800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.377200E-01
Normal-vs-Age(41-60Yrs)
9.832000E-01
Normal-vs-Age(61-80Yrs)
8.628800E-01
Normal-vs-Age(81-100Yrs)
6.394200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.341600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.882200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.525400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.892200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.207000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.697200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.939800E-01
Normal-vs-Daily Drinker
8.105800E-01
Normal-vs-Weekly Drinker
8.229000E-01
Normal-vs-Occasional Drinker
6.715800E-01
Normal-vs-Social Drinker
6.105600E-01
Non Drinker-vs-Daily Drinker
2.518000E-02
Non Drinker-vs-Weekly Drinker
4.842100E-02
Non Drinker-vs-Occasional Drinker
1.325660E-02
Non Drinker-vs-Social Drinker
2.012600E-01
Daily Drinker-vs-Weekly Drinker
9.726800E-01
Daily Drinker-vs-Occasional Drinker
6.668200E-01
Daily Drinker-vs-Social Drinker
1.907970E-01
Weekly Drinker-vs-Occasional Drinker
6.770400E-01
Weekly Drinker-vs-Social Drinker
2.718400E-01
Occasional Drinker-vs-Social Drinker
1.152430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.978400E-01
Normal-vs-Grade 2
8.897000E-01
Normal-vs-Grade 3
8.399200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.523400E-01
Grade 1-vs-Grade 3
9.339200E-01
Grade 1-vs-Grade 4
5.978400E-01
Grade 2-vs-Grade 3
1.825010E-01
Grade 2-vs-Grade 4
8.897000E-01
Grade 3-vs-Grade 4
8.399200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.472800E-01
Normal-vs-NonDiabetic
9.186200E-01
Diabetic-vs-NonDiabetic
9.679100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.742600E-01
Normal-vs-NoPancreatitis
9.040400E-01
Pancreatitis-vs-NoPancreatitis
7.625200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.468000E-01
Normal-vs-N1
7.771000E-01
N0-vs-N1
2.265800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.660000E-01
Normal-vs-TP53-NonMutant
9.667800E-01
TP53-Mutant-vs-TP53-NonMutant
5.999600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
